Total Payments
$97,594
2024 Payments
$4,129
Companies
47
Transactions
815
Medicare Patients
5,145
Medicare Billing
$433,426
Payment Breakdown by Category
Other$71,778 (73.5%)
Food & Beverage$14,171 (14.5%)
Consulting$4,370 (4.5%)
Travel$3,654 (3.7%)
Education$3,231 (3.3%)
Gifts$390.00 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $71,778 | 48 | 73.5% |
| Food and Beverage | $14,171 | 735 | 14.5% |
| Consulting Fee | $4,370 | 5 | 4.5% |
| Travel and Lodging | $3,654 | 17 | 3.7% |
| Education | $3,231 | 9 | 3.3% |
| Gift | $390.00 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $83,358 | 244 | $0 (2024) |
| Intuitive Surgical, Inc. | $3,427 | 4 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,718 | 112 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,480 | 58 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $744.39 | 24 | $0 (2024) |
| Mylan Specialty L.P. | $717.74 | 40 | $0 (2024) |
| Grifols USA, LLC | $657.14 | 35 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $585.28 | 29 | $0 (2024) |
| GENZYME CORPORATION | $485.39 | 26 | $0 (2024) |
| Genentech USA, Inc. | $382.81 | 35 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,129 | 99 | Boehringer Ingelheim Pharmaceuticals, Inc. ($2,207) |
| 2023 | $25,583 | 129 | Boehringer Ingelheim Pharmaceuticals, Inc. ($20,178) |
| 2022 | $12,043 | 96 | Boehringer Ingelheim Pharmaceuticals, Inc. ($10,982) |
| 2021 | $9,013 | 89 | Boehringer Ingelheim Pharmaceuticals, Inc. ($8,087) |
| 2020 | $4,586 | 78 | Boehringer Ingelheim Pharmaceuticals, Inc. ($3,580) |
| 2019 | $18,930 | 143 | Boehringer Ingelheim Pharmaceuticals, Inc. ($16,986) |
| 2018 | $8,222 | 92 | Boehringer Ingelheim Pharmaceuticals, Inc. ($6,872) |
| 2017 | $15,088 | 89 | Boehringer Ingelheim Pharmaceuticals, Inc. ($14,466) |
All Payment Transactions
815 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Pulmonology | ||||||
| 12/19/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/19/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $1.51 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.73 | General |
| Category: Immunology | ||||||
| 12/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: VACCINES | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $4.37 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/03/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Inflammation | ||||||
| 11/01/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/28/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: Inflammation | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.91 | General |
| 10/23/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Cardiology | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $102.76 | General |
| 10/22/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Inflammation | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: Immunology | ||||||
| 10/08/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,607 | 1,778 | $373,263 | $124,310 |
| 2022 | 24 | 1,366 | 1,549 | $335,200 | $115,617 |
| 2021 | 20 | 1,220 | 1,401 | $289,782 | $108,050 |
| 2020 | 15 | 952 | 1,183 | $248,806 | $85,449 |
Total Patients
5,145
Total Services
5,911
Medicare Billing
$433,426
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 313 | 423 | $102,789 | $37,143 | 36.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 126 | 126 | $40,068 | $15,273 | 38.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 93 | 110 | $37,730 | $14,269 | 37.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 61 | 66 | $27,786 | $10,539 | 37.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 54 | 54 | $22,734 | $8,493 | 37.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 179 | 187 | $19,822 | $7,426 | 37.5% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 179 | 187 | $18,887 | $7,236 | 38.3% |
| 31629 | Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | Facility | 2023 | 22 | 22 | $8,932 | $2,978 | 33.3% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 95 | 97 | $7,663 | $2,704 | 35.3% |
| 31653 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | Facility | 2023 | 13 | 13 | $6,942 | $2,236 | 32.2% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 88 | 93 | $8,742 | $1,902 | 21.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 19 | $3,781 | $1,745 | 46.1% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2023 | 23 | 23 | $4,853 | $1,687 | 34.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 25 | $3,425 | $1,526 | 44.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 67 | 70 | $5,161 | $1,364 | 26.4% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 29 | 29 | $11,107 | $1,242 | 11.2% |
| 31654 | Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | Facility | 2023 | 24 | 24 | $3,504 | $1,221 | 34.8% |
| 31652 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | Facility | 2023 | 11 | 11 | $5,302 | $1,092 | 20.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 34 | 35 | $3,850 | $982.10 | 25.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 16 | $2,752 | $885.30 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 11 | 11 | $2,090 | $824.78 | 39.5% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 41 | 41 | $11,931 | $761.48 | 6.4% |
| 76000 | Imaging guidance for procedure, 60 minutes or less | Facility | 2023 | 28 | 28 | $840.00 | $334.88 | 39.9% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 13 | 14 | $1,190 | $317.38 | 26.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 13 | 15 | $150.00 | $126.00 | 84.0% |
About Dr. John Thompson, M.D
Dr. John Thompson, M.D is a Critical Care Medicine healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760496301.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Thompson, M.D has received a total of $97,594 in payments from pharmaceutical and medical device companies, with $4,129 received in 2024. These payments were reported across 815 transactions from 47 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($71,778).
As a Medicare-enrolled provider, Thompson has provided services to 5,145 Medicare beneficiaries, totaling 5,911 services with total Medicare billing of $433,426. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Lexington, KY
- Active Since 07/28/2006
- Last Updated 12/03/2020
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1760496301
Products in Payments
- OFEV (Drug) $33,379
- ION (Device) $3,000
- DUPIXENT (Biological) $1,100
- NUCALA (Biological) $716.13
- TRELEGY ELLIPTA (Drug) $701.30
- STIOLTO RESPIMAT (Drug) $684.06
- Prolastin-C Liquid (Biological) $626.73
- FASENRA (Drug) $505.98
- Da Vinci Surgical System (Device) $426.80
- YUPELRI (Drug) $401.19
- UPTRAVI (Drug) $345.15
- OPSUMIT (Drug) $332.00
- Xolair (Biological) $331.62
- Yupelri (Drug) $300.21
- SPIRIVA RESPIMAT (Drug) $276.23
- TYVASO (Drug) $263.44
- GLASSIA (Biological) $259.67
- FASENRA (Biological) $242.52
- TEZSPIRE (Biological) $216.02
- XOLAIR (Biological) $208.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Lexington
Jimmy Smith, D.o, D.O
Critical Care Medicine — Payments: $353,296
Critical Care Medicine $353,296
Girish Nair, Md, MD
Critical Care Medicine — Payments: $75,636
Critical Care Medicine $75,636
Adam Betz, M.d, M.D
Critical Care Medicine — Payments: $22,193
Critical Care Medicine $22,193
Dr. Theresa Case, D.o, D.O
Critical Care Medicine — Payments: $15,431
Critical Care Medicine $15,431
Eliseo Colon-Carreras, Md, MD
Critical Care Medicine — Payments: $8,414
Critical Care Medicine $8,414
Anthony Gerber, Md, MD
Critical Care Medicine — Payments: $8,073
Critical Care Medicine $8,073